Profound Medical Corp. (PROF) Tops Q1 EPS by 69c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street ends higher after Democrats win Congress; data center stocks tumble
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mailGet Alerts PROF Hot Sheet
Join SI Premium – FREE
Profound Medical Corp. (NASDAQ: PROF) reported Q1 EPS of $0.32, $0.69 better than the analyst estimate of ($0.37). Revenue for the quarter came in at $1.86 million versus the consensus estimate of $2.12 million.
For earnings history and earnings-related data on Profound Medical Corp. (PROF) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Vertex (VERX) Tops Q3 EPS by 4c; Offers Guidance
- CrossAmerica Partners (CAPL) Misses Q3 EPS by 8c
- Veeco Instruments (VECO) Misses Q3 EPS by 9c; Offers Guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
